JPWO2020067453A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020067453A5
JPWO2020067453A5 JP2020549451A JP2020549451A JPWO2020067453A5 JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5 JP 2020549451 A JP2020549451 A JP 2020549451A JP 2020549451 A JP2020549451 A JP 2020549451A JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5
Authority
JP
Japan
Prior art keywords
weight
preparation according
lyophilized preparation
peptide
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020549451A
Other languages
English (en)
Japanese (ja)
Other versions
JP7162675B2 (ja
JPWO2020067453A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/038223 external-priority patent/WO2020067453A1/ja
Publication of JPWO2020067453A1 publication Critical patent/JPWO2020067453A1/ja
Publication of JPWO2020067453A5 publication Critical patent/JPWO2020067453A5/ja
Application granted granted Critical
Publication of JP7162675B2 publication Critical patent/JP7162675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020549451A 2018-09-28 2019-09-27 注射用組成物 Active JP7162675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018185532 2018-09-28
JP2018185532 2018-09-28
PCT/JP2019/038223 WO2020067453A1 (ja) 2018-09-28 2019-09-27 注射用組成物

Publications (3)

Publication Number Publication Date
JPWO2020067453A1 JPWO2020067453A1 (ja) 2021-09-09
JPWO2020067453A5 true JPWO2020067453A5 (https=) 2022-04-08
JP7162675B2 JP7162675B2 (ja) 2022-10-28

Family

ID=69951879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020549451A Active JP7162675B2 (ja) 2018-09-28 2019-09-27 注射用組成物

Country Status (10)

Country Link
US (1) US20210338587A1 (https=)
EP (1) EP3858377A4 (https=)
JP (1) JP7162675B2 (https=)
KR (1) KR20210068060A (https=)
CN (1) CN113382746A (https=)
AU (1) AU2019349329A1 (https=)
CA (1) CA3113212A1 (https=)
MX (1) MX2021003660A (https=)
NZ (1) NZ774063A (https=)
WO (1) WO2020067453A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024149926A (ja) * 2021-08-06 2024-10-23 ブライトパス・バイオ株式会社 がんペプチドワクチンカクテル製剤、及びその製造方法
WO2024233672A1 (en) * 2023-05-08 2024-11-14 Integro Theranostics, Llc Lyophilized products, pharmaceutical compositions, and kits comprising dye-peptide conjugates and derivatives

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1560078B (zh) 1998-07-31 2011-06-22 株式会社国际癌症免疫研究所 基于癌抑制基因wt1的产物的癌抗原
US20030235557A1 (en) 1998-09-30 2003-12-25 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US20030072767A1 (en) 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
ATE399179T1 (de) 1998-09-30 2008-07-15 Corixa Corp Zusammensetzungen und verfahren für wt1- spezifische immunotherapie
US20050050580A1 (en) 2000-12-13 2005-03-03 Masashi Gotoh Transgenic animal expressing hla-a24 and utilization thereof
ES2298353T3 (es) 2001-03-22 2008-05-16 International Institute Of Cancer Immunology, Inc. Peptido wt1 modificado.
US7553494B2 (en) 2001-08-24 2009-06-30 Corixa Corporation WT1 fusion proteins
WO2003106682A1 (ja) 2002-06-12 2003-12-24 中外製薬株式会社 Hla−a24拘束性癌抗原ペプチド
ATE442378T1 (de) 2002-09-20 2009-09-15 Int Inst Cancer Immunology Inc Substituierte wt1-peptide
US7353321B2 (en) 2003-01-13 2008-04-01 Sierra Logic Integrated-circuit implementation of a storage-shelf router and a path controller card for combined use in high-availability mass-storage-device shelves that may be incorporated within disk arrays
CN101580538B (zh) 2003-11-05 2013-06-19 株式会社国际癌症免疫研究所 Wt1衍生的hla-dr-结合抗原肽
EP2478913A1 (en) 2003-12-01 2012-07-25 Sloan-Kettering Institute For Cancer Research Synthetic HLA binding peptide analogues and uses thereof
WO2006078059A1 (ja) 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. 希釈用乳化組成物および癌ワクチン組成物
ES2542141T3 (es) 2005-10-17 2015-07-31 Sloan Kettering Institute For Cancer Research Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
ES2352855T3 (es) 2005-11-30 2011-02-23 International Institute Of Cancer Immunology, Inc. Nuevos compuestos peptídicos del tumor de wilms.
PL2010209T3 (pl) 2006-04-10 2017-04-28 Sloan Kettering Inst For Cancer Res Immunogeniczne peptydy WT-1 i sposoby ich użycia
WO2009046738A1 (en) * 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
WO2010037395A2 (en) 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
AR076349A1 (es) 2009-04-23 2011-06-01 Int Inst Cancer Immunology Inc Peptido auxiliar del antigeno del cancer
MY171854A (en) * 2013-03-29 2019-11-05 Sumitomo Dainippon Pharma Co Ltd Wt1 antigen peptide conjugate vaccine
JP6580581B2 (ja) 2014-09-27 2019-09-25 大日本住友製薬株式会社 注射用医薬組成物
JP6515182B2 (ja) 2015-05-20 2019-05-15 大日本住友製薬株式会社 Wt1抗原ペプチドおよび免疫調節剤の併用
EP3549957A4 (en) 2016-11-30 2020-08-05 Sumitomo Dainippon Pharma Co., Ltd. AUXILIARY PEPTIDE WT1, AND COMBINATION OF DUDIT PEPTIDE AND CONJUGATE PEPTIDE ANTIGENIC FOR CANCER

Similar Documents

Publication Publication Date Title
JP2016065060A5 (https=)
JP2020138981A5 (https=)
JP2019504086A5 (https=)
JP2019131596A5 (https=)
JP2020518599A5 (https=)
CA3040110A1 (en) Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications
JPWO2020067453A5 (https=)
JP2011513492A5 (https=)
JP2013525501A5 (https=)
JP2016505044A5 (https=)
JP2018528242A5 (https=)
JP2013531679A5 (https=)
JP2013513612A5 (https=)
JP2020015742A5 (https=)
US20240261398A1 (en) Adjuvant and vaccine containing adjuvant
JP2012516879A5 (https=)
EP2593135B1 (fr) Souches virales modifiées et procédé pour améliorer la production de semences vaccinales de virus influenza
JP2019516730A5 (https=)
CA3142740A1 (en) Influenza virus backbone
JP2021502337A5 (https=)
US12606804B2 (en) Influenza virus backbone
JP2016517435A5 (ja) メロペネム誘導体及びその製造法
JP2014524450A5 (https=)
JP2022510947A5 (https=)
JP5189088B2 (ja) 抗ウイルス剤